About Edelris
EDELRIS is a MedChem-oriented Research & Service based company, dedicated to the design and production of innovative, therapeutically relevant, natural-mimetic screening compounds. Aiming at the acceleration of the hit/lead discovery process in pharmaceutical and biotech research organizations, EDELRIS uses its track-proven chemistry and drug discovery expertise to provide novelty to its customers with exclusive or non-exclusive small molecules and with efficient hit/lead optimization capabilities.
Advertisement
News about Edelris
Here you will find Edelris
Last viewed contents
The spider with the bee venom - New perspectives for the search for active substances against cell-based diseases - Researchers decode the toxin arsenal of the most poisonous native spider species
Spirea Ltd - Harrogate, United Kingdom
LETI Pharma GmbH - Ismaning, Germany
Opening the door to affordable lab-grown beef, cow cells defy aging - A potential game-changer for creating sustainable, ethical meat without the environmental toll of traditional livestock farming
EMD Serono, Inc. - Rockland, USA
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Being fit Protects Against Health Risks Caused by Stress at Work
WIKA strengthens management team with Axel Schwerdtfeger - Process Solutions company division under new leadership
F-star - Wien, Austria
Chemical pollution threatens biodiversity - Scientists say more environmental pollutants should be considered in species protection
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government - Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency